Henry Chen

Investments

Per the firm's website.

Colleagues at Delos Capital

AK

Agnes Kwok

Financial Controller at Delos Capital

AL

Andrea Lok

Executive Assistant at Delos Capital

CG

Carrie Greenaway

Office Manager at Delos Capital

EH

Eric Huang

Partner at Delos Capital

HH

Hank Huang

Associate at Delos Capital

LC

Lee Cooper

Managing Director at Delos Capital

PS

Paul Shen

Operations Manager at Delos Capital

TP

Tej Pavoor

Partner at Delos Capital

Frequently asked questions

Who is Henry Chen?

Henry Chen founded Delos Capital in 2014 and serves as its Managing Partner. He was previously a Partner and Co-Head of Asia at Permira, and earlier spent nine years at Goldman Sachs as a Managing Director and co-head of the General Industrials Group for Asia (ex-Japan), following corporate finance law work at Davis Polk. He has co-founded Curamir Therapeutics and Tulavi Therapeutics and served as CEO and Chairman of Tanvex BioPharma, and holds bachelor's and master's degrees from Harvard University and a JD from Harvard Law School.

Where does Henry Chen work?

Henry Chen is Managing Partner at Delos Capital and Board director at Curamir Therapeutics and Board director at Tulavi Therapeutics and Board director at Instylla Inc.

What boards does Henry Chen sit on?

Henry Chen holds tracked board seats at Tanvex BioPharma Inc..

What companies has Henry Chen invested in?

Investments tracked here include Curamir Therapeutics Inc., Tulavi Therapeutics.

Where did Henry Chen go to school?

Henry Chen studied at Harvard Law School (JD); Harvard University (Master of Arts (M.A.), History of Science); Harvard University (AB, History and Science).